NICOLE VITULLO
CIK 1196863 · last filed 2025-06-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$211.93M
Companies
23
Total Filings
108
Lifetime Open-Market Net
$61.17M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ESPR | Director | 36,918 | $3.15 | $116.3K | $1.97M | 17 | 2025-06-02 |
| MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Director | 6,442 | $0.55 | $3.5K | -$67.4K | 14 | 2022-02-07 |
| ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | Director | 0 | — | — | -$5.96M | 21 | 2020-01-29 |
| Vyome Holdings, Inc (OBLN) Delisted | 10%+ Owner | 3,985,970 | $9.15 | $36.47M | $0 | 1 | 2016-10-14 |
| CoLucid Pharmaceuticals, Inc. (CLCD) Delisted | 10%+ Owner | 2,024,203 | — | — | -$6.47M | 1 | 2016-08-03 |
| Celator Pharmaceuticals Inc (CPXX) Delisted | Director | 0 | — | — | $0 | 2 | 2016-07-12 |
| Evoke Pharma Inc (OMED) Delisted | 10%+ Owner | 625,289 | — | — | -$9.70M | 2 | 2016-05-27 |
| SNDX | 10%+ Owner | 761,062 | $18.25 | $13.89M | $0 | 1 | 2016-03-08 |
| Tobira Therapeutics, Inc. (TBRA) Delisted | 10%+ Owner | 38,094 | — | — | $0 | 1 | 2015-05-06 |
| Evofem Biosciences, Inc. (NEOT) Delisted | 10%+ Owner | 49,750 | — | — | $0 | 2 | 2014-12-10 |
| Durata Therapeutics, Inc. (DRTX) Delisted | Director | 22,306 | — | — | $7.06M | 2 | 2014-11-18 |
| Achaogen, Inc. (AKAO) Delisted | 10%+ Owner | 33,890 | — | — | $0 | 1 | 2014-03-17 |
| CADENCE PHARMACEUTICALS INC (CADX) Delisted | 10%+ Owner | 3,019,312 | — | — | $12.57M | 12 | 2014-02-14 |
| Dicerna Pharmaceuticals Inc (DRNA) Delisted | 10%+ Owner | 1,752,707 | $38.22 | $66.99M | $0 | 1 | 2014-02-04 |
| ALIMERA SCIENCES INC (ALIM) Delisted | 10%+ Owner | 53,771 | $5.54 | $297.9K | $3.97M | 4 | 2014-01-17 |
| TNDM | 10%+ Owner | 3,189,058 | $16.60 | $52.94M | $0 | 1 | 2013-11-19 |
| VCYT | 10%+ Owner | 3,063,294 | $47.33 | $144.99M | $0 | 1 | 2013-11-04 |
| Tobira Therapeutics, Inc. (RGDO) Delisted | 10%+ Owner | 430,516 | — | — | $3.00M | 1 | 2013-08-28 |
| Ocera Therapeutics, Inc. (TZYM) Delisted | 10%+ Owner | 47,963 | — | — | $8.00M | 1 | 2013-07-16 |
| Orexigen Therapeutics, Inc. (OREX) Delisted | 10%+ Owner | 2,967,415 | — | — | $18.29M | 12 | 2011-12-22 |
| Clovis Oncology, Inc. (CLVS) Delisted | 10%+ Owner | 35,388 | $0.08 | $2.9K | $12.11M | 1 | 2011-11-21 |
| ZOGENIX, INC. (ZGNX) Delisted | 10%+ Owner | 9,923,335 | $26.68 | $264.75M | $16.40M | 2 | 2011-09-20 |
| Volcano Corp (VOLC) Delisted | 10%+ Owner | 61,860 | — | — | $0 | 2 | 2008-06-09 |
Recent Filings · Page 2 of 11
108 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-01-29 | ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | Disp (D) | −3,454,972 | -$21.77M | EDGAR |
| 2020-01-10 | MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-31 | ESPR | Grant (A) | +4,967 | $0 | EDGAR |
| 2019-03-21 | ESPR | Mixed | −1,115,053 | -$685.6K | EDGAR |
| 2019-02-28 | MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-01-25 | ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-26 | ESPR | Other (J) | −17,625 | $0 | EDGAR |
| 2018-06-04 | ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | Other (J) | −20,000 | $0 | EDGAR |
| 2018-05-25 | ESPR | Grant (A) | — | $0 | EDGAR |
| 2018-02-13 | ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.